Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study Publisher Pubmed



Salehi Z1, 2 ; Almasihashiani A3 ; Sahraian MA2 ; Ashtari F4 ; Baghbanian SM5 ; Razazian N6 ; Moghadasi AN2 ; Bayati A7 ; Azimi AR2 ; Beladimoghadam N8 ; Harirchian MH9 ; Poursadeghfard M10 ; Navardi S2 ; Shirkoohi R11 Show All Authors
Authors
  1. Salehi Z1, 2
  2. Almasihashiani A3
  3. Sahraian MA2
  4. Ashtari F4
  5. Baghbanian SM5
  6. Razazian N6
  7. Moghadasi AN2
  8. Bayati A7
  9. Azimi AR2
  10. Beladimoghadam N8
  11. Harirchian MH9
  12. Poursadeghfard M10
  13. Navardi S2
  14. Shirkoohi R11
  15. Heidari H2
  16. Ghaffari M8
  17. Eskandarieh S2
Show Affiliations
Authors Affiliations
  1. 1. Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Sina Hospital, Hassan Abad Square, Tehran, Iran
  3. 3. Department of Epidemiology, School of Health, Arak University of Medical Sciences, Arak, Iran
  4. 4. Isfahan Neurosciences Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Neurology, Booalicina Hospital, Mazandaran University of Medical Sciences, Sari, Iran
  6. 6. Department of Neurology, Medicine Faculty, Kermanshah University of Medical Sciences, Kermanshah, Iran
  7. 7. Department of Neurology, Shahrekord University of Medical Sciences and Health Services, Shahrekord, Iran
  8. 8. Department of Neurology, Shahid Beheshti University of Medical Sciences, Tehran, Iran
  9. 9. Iranian Centre of Neurological Research, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran
  10. 10. Clinical Neurology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  11. 11. Cancer Research Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran

Source: BMC Neurology Published:2022


Abstract

Background: Admittedly, little is known about the epidemiological signatures of familial multiple sclerosis (FMS) in different geographical regions of Iran. Objective: To determine the epidemiology and the risk of FMS incidence in several provinces of Iran with a different ethnic population including, Fars, Tehran, Isfahan (Persians), and Mazandaran (Mazanis), Kermanshah (Kurds), and Chaharmahal and Bakhtiari (Lors). Methods: This cross-sectional registry-based study was performed on nationwide MS registry of Iran (NMSRI) data collected from 2018 to 2021. This system, registers baseline characteristics, clinical presentations and symptoms, diagnostic and treatments at regional and national levels. Results: A total of 9200 patients including, 7003 (76.1%) female and 2197 (23.9%) male, were participated. About 19% of patients reported a family history of MS; the order from highest to lowest FMS prevalence was as follows: Fars (26.5%), Chaharmahal and Bakhtiari (21.1%), Tehran (20.5%), Isfahan (20.3%), Mazandaran (18.0%), and Kermanshah (12.5%). Of all FMS cases, 74.7% (1308 cases) were female and 25.3% (442 cases) were male. FMS occurrence was much more common in females than males (P-value = 0.001). Further, the mean age at onset was 30 years among FMS cases. A substantially higher probability of relapsing-remitting MS and secondary-progressive MS was found among FMS cases than sporadic MS (SMS) (P_value = 0.001). There was no significant difference in Expanded Disability Status Scale (EDSS) scores between FMS and SMS. The majority of FMS cases were observed among first-degree relatives, with the highest rate in siblings. There was a significant association between MS risk and positive familial history in both maternal and paternal aunt/uncle (P_value = 0.043 and P_value = 0.019, respectively). Multiple sclerosis occurrence among offspring of females was higher than males (P_value = 0.027). Conclusions: In summary, our findings imply a noteworthy upward trend of FMS in Iran, even more than the global prevalence, which suggests a unique Atlas of FMS prevalence in this multi-ethnic population. Despite the highest rate of FMS within Persian and Lor ethnicities, no statistically significant difference was observed among the provinces. © 2022, The Author(s).
Other Related Docs
13. Multiple Sclerosis in Isfahan, Iran, International Review of Neurobiology (2007)
18. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)
22. Characteristics of Covid-19 in Patients With Multiple Sclerosis, Multiple Sclerosis and Related Disorders (2022)
34. Lateonset Multiple Sclerosis in Isfahan, Iran, Archives of Iranian Medicine (2012)
35. Multiple Sclerosis Among Afghan Immigrants in Isfahan, Iran, Multiple Sclerosis and Related Disorders (2017)